MicroPort India enters into an exclusive agreement with Corindus Vascular Robotics, USA to bring vascular robotics to India. CorPath GRX is the first and only robotic platform US FDA cleared to bring precision to both Percutaneous Coronary Intervention (PCI) and Peripheral Vascular Intervention (PVI) procedures.
What Is Robotic-Assisted PCI?
The Benefits of Precision Vascular Robotics
Today, many procedures that were once highly invasive are now being performed via minimally invasive techniques, with the added benefit of robotic precision and radiation protection.
Manual Vs. Robotic-Assisted PCI
Since the introduction of PCI 40 years ago, there has been an astonishing amount of advancement in the technology and devices used in the procedure, however the way the procedure is performed has remained virtually unchanged. Now, robotics has the potential to overcome some of the current limitations of the traditional manual approach to PCI.
Robotic Precision May Improve Outcomes, Economics & Safety
At times a struggle to see
Close proximity, ergonomic visualization
Trial and error, wire spinning
Precise ‘Point & Shoot’ predictablility
‘Eyeball’ estimate or
Robotic-assisted sub-mm measurement
1 mm precise positioning
Devices loose during inflation
Devices held in place during deployment
Potential to reduce
Significantly reduces radiation for primary operator and potential to decrease for staff
How It Works
CorPath GRX Precision Vasuclar Robotics
The CorPath GRX Vascular Robotic System provides value for physicians, staff, and patients:
Robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent catheters.
Sub-millimeter measurement and 1mm movement to position stents exactly where you need them.
Extended Reach Arm for radial access and redesigned Bedside Unit with touchscreen for ease of use.
Radiation protection to the physician and potential to reduce radiation exposure for staff and patients.
Robotic-assisted control of guide catheter enables necessary adjustments during complex cases.
Radiation Shield &
Power Vision Monitor
Work from a seated position without wearing lead. Optional 40” widescreen monitor with 4K resolution enhances clinical visualization.
Simplify technologist workflow with on-screen procedure status and instructions for use.
Proven Patient & Provider Benefit
CorPath GRX is a second generation robotic-assisted PCI system built on the foundation of the CorPath 200’s clinical success with over 3,000 cases across more than 40 cardiovascular programs worldwide.
When using the CorPath System, studies have shown:*
Clinical Success in Complex Cases
The CORA-PCI Trial demonstrated 99.1% clinical success in complex cases along with comparable procedure times to manual PCI.
Radiation Reduction to Physicians
The PRECISE trial demonstrated a 95% reduction in radiation exposure to the primary operator.
Radiation Reduction to the Patient
A single center retrospective study published in the Journal of Invasive Cardiology demonstrated a 17% reduction in radiation dose to the patient compared to manual PCI.
Reduction in Stent Usage
A recent study demonstrated that accurate measurement of coronary anatomy, using CorPath, reduced the use of unnecessary additional stents by 8.3%.
The CorPath GRX System is intended for the use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary and vascular procedures.